Enter age, AST, ALT, and platelet count to calculate
Evidence
Original publication
Sterling RK, Lissen E, Clumeck N, et al. Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfection. FIB-4 = (age·AST)/(platelets·√ALT); < 1.45 had a 90% negative predictive value for advanced fibrosis and > 3.25 a 65% positive predictive value, avoiding biopsy in ~70% of patients.
Hepatology, 2006
Open source
Validation
FIB-4 has since been validated in chronic hepatitis C, hepatitis B, and non-alcoholic fatty liver disease; in adults over ~65 the lower cut-off is commonly raised to 2.0 to preserve specificity.
Guideline
The 2023 AASLD NAFLD/MASLD guidance and the EASL–EASD–EASO guideline recommend FIB-4 as the first-line non-invasive test to risk-stratify for advanced fibrosis in primary and specialist care.
Last reviewed: 2026-09
Report an error in this calculator
MedScore is an educational and clinical decision-support tool. It does not provide a diagnosis, a treatment, or a drug-dosing recommendation, and it does not replace clinical judgement or local guidelines. Confirm every result against the original source before acting on it. The treating clinician remains responsible for all decisions.